Two Sigma Investments’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101M | Buy |
2,339,067
+1,495,746
| +177% | +$64.6M | 0.18% | 151 |
|
|
2025
Q1 | $29.2M | Buy |
843,321
+604,785
| +254% | +$20.9M | 0.06% | 359 |
|
|
2024
Q4 | $6.55M | Sell |
238,536
-142,706
| -37% | -$3.92M | 0.01% | 908 |
|
|
2024
Q3 | $9.71M | Sell |
381,242
-184,210
| -33% | -$4.69M | 0.02% | 736 |
|
|
2024
Q2 | $14.3M | Sell |
565,452
-179,148
| -24% | -$4.54M | 0.03% | 545 |
|
|
2024
Q1 | $23M | Sell |
744,600
-222,197
| -23% | -$6.87M | 0.05% | 381 |
|
|
2023
Q4 | $39M | Sell |
966,797
-310,287
| -24% | -$12.5M | 0.09% | 253 |
|
|
2023
Q3 | $33.7M | Buy |
1,277,084
+536,693
| +72% | +$14.2M | 0.09% | 252 |
|
|
2023
Q2 | $12.7M | Sell |
740,391
-39,149
| -5% | -$673K | 0.03% | 507 |
|
|
2023
Q1 | $12.9M | Buy |
779,540
+128,329
| +20% | +$2.13M | 0.04% | 471 |
|
|
2022
Q4 | $4.96M | Sell |
651,211
-219,996
| -25% | -$1.68M | 0.02% | 834 |
|
|
2022
Q3 | $8.66M | Buy |
871,207
+719,944
| +476% | +$7.16M | 0.03% | 522 |
|
|
2022
Q2 | $1.37M | Sell |
151,263
-358,285
| -70% | -$3.25M | ﹤0.01% | 1342 |
|
|
2022
Q1 | $5.17M | Sell |
509,548
-96,641
| -16% | -$981K | 0.02% | 888 |
|
|
2021
Q4 | $10.1M | Buy |
606,189
+559,467
| +1,197% | +$9.33M | 0.02% | 629 |
|
|
2021
Q3 | $2.19M | Buy |
46,722
+31,043
| +198% | +$1.46M | ﹤0.01% | 1311 |
|
|
2021
Q2 | $956K | Sell |
15,679
-468,149
| -97% | -$28.5M | ﹤0.01% | 1694 |
|
|
2021
Q1 | $29.8M | Buy |
483,828
+319,239
| +194% | +$19.7M | 0.08% | 266 |
|
|
2020
Q4 | $11.7M | Buy |
164,589
+32,414
| +25% | +$2.3M | 0.03% | 473 |
|
|
2020
Q3 | $4.96M | Buy |
+132,175
| New | +$4.96M | 0.02% | 612 |
|